Discontinued Operations and Divestitures (Tables)

9 Months Ended

Sep. 28, 2018

Sep. 29, 2017

Specialty Generics Disposal Group

Schedule of Income (Loss) from Discontinued Operations

The following table summarizes the financial results of the Specialty Generics Disposal Group presented in the unaudited condensed consolidated statements of income:

	Three Months Ended					Nine Months Ended
	September 28, 2018		September 29, 2017			September 28, 2018		September 29, 2017
Major line items constituting income from discontinued operations:
Net sales	$	159.9	$	193.3		$	536.4	$	668.6
Cost of sales	107.3		125.3			336.1		384.5
Selling, general and administrative expenses	29.4		19.3			73.8		56.6
Research and development expenses	7.6		12.6			36.8		46.3
Restructuring charges, net	0.1		(1.1		)	5.3		5.8
Non-restructuring impairment charges	2.0		—			2.0		—
Other income, net	—		0.6			0.3		4.4
Income from discontinued operations	13.5		37.8			82.7		179.8
Income tax expense	2.3		26.6			18.1		42.6
Income from discontinued operations, net of income taxes	$	11.2	$	11.2		$	64.6	$	137.2

Schedule of Major Classes of Assets and Liabiltiies Held For Sale

The following table summarizes the assets and liabilities of the Specialty Generics Disposal Group that are classified as held for sale on the unaudited condensed consolidated balance sheets:

	September 28, 2018		December 29, 2017
Carrying amounts of major classes of assets included as part of discontinued operations:
Accounts receivable	$	189.0	$	170.4
Inventories	205.9		211.7
Property, plant and equipment, net	561.7		553.6
Intangible assets, net	110.3		114.0
Other current and non-current assets	69.9		84.5
Total assets classified as held for sale in the balance sheet	$	1,136.8	$	1,134.2
Carrying amounts of major classes of liabilities included as part of discontinued operations:
Accounts payable	$	39.0	$	36.0
Other current and non-current liabilities	143.4		126.6
Total liabilities classified as held for sale in the balance sheet	$	182.4	$	162.6

Schedule of Significant Cash and Non-Cash Transactions

The following table summarizes significant cash and non-cash transactions of the Specialty Generics Disposal Group that are included within the unaudited condensed consolidated statements of cash flows for the respective periods:

	Three Months Ended				Nine Months Ended
	September 28, 2018		September 29, 2017		September 28, 2018		September 29, 2017
Depreciation, including accelerated depreciation	$	0.6	$	15.3	$	12.1	$	45.7
Amortization	—		3.9		1.7		14.6
Capital expenditures	5.9		11.1		21.7		41.7

Nuclear Imaging

Schedule of Income (Loss) from Discontinued Operations

The following table summarizes the financial results of the Nuclear Imaging business presented in the unaudited condensed consolidated statements of income:

	Three Months Ended			Nine Months Ended
	September 29, 2017			September 29, 2017
Major line items constituting income from discontinued operations:
Net sales	$	—		$	31.6
Cost of sales	—			15.6
Selling, general and administrative expenses	—			7.8
Other	—			(0.2		)
Income from discontinued operations	—			8.4
(Loss) gain on divestiture of discontinued operations	(0.6		)	362.8
(Loss) income from discontinued operations, before income taxes	(0.6		)	371.2
Income tax (benefit) expense	(0.1		)	5.2
(Loss) income from discontinued operations, net of income taxes	$	(0.5	)	$	366.0